Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Oct 12, 2025 | (Q1)Jul 20, 2025 | (FY)Apr 27, 2025 | (Q4)Apr 27, 2025 | (Q3)Feb 2, 2025 | (Q2)Oct 13, 2024 | (Q1)Jul 21, 2024 | (FY)Apr 28, 2024 | (Q4)Apr 28, 2024 | (Q3)Feb 4, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -9.37%1.2B | 28.64%1.26B | 4.56%5.04B | 17.59%1.79B | -3.78%938M | 42.35%1.33B | -29.23%983.1M | 10.88%4.82B | 6.78%1.52B | 974.8M |
| Net income from continuing operations | 4.40%743.3M | -0.88%786.1M | -5.12%2.59B | -2.68%442.3M | 3.30%645M | -13.09%712M | -4.92%793.1M | -11.61%2.73B | -32.23%454.5M | --624.4M |
| Operating gains losses | -114.02%-22.9M | 49.12%-23.2M | -246.80%-50.5M | -40.35%30.3M | 88.99%-7.4M | -118.10%-10.7M | -470.00%-45.6M | 127.52%34.4M | 165.30%50.8M | ---67.2M |
| Depreciation and amortization | 13.97%535.9M | 19.62%528.6M | 19.63%2.11B | 9.03%542.3M | 22.67%657.4M | 26.91%470.2M | 22.24%441.9M | 15.12%1.77B | 26.76%497.4M | --535.9M |
| Unrealized gains and losses of investment securities | ---- | -203.45%-26.4M | -48.40%12.9M | ---- | ---- | ---- | -2,800.00%-8.7M | -16.67%25M | ---- | ---- |
| Deferred tax | 52.94%57.2M | 250.46%113.9M | 143.80%147.5M | 138.49%9.7M | 6.59%67.9M | 458.21%37.4M | 112.42%32.5M | -25.22%60.5M | -166.84%-25.2M | --63.7M |
| Other non cashItems | 30.61%32M | -31.22%15.2M | 139.78%88M | 402.02%49.7M | -166.80%-16.7M | 285.61%24.5M | 47.33%22.1M | -26.16%36.7M | 209.38%9.9M | --25M |
| Change In working capital | -246.72%-140.7M | 48.65%-129.5M | -17.23%135M | 37.97%699.5M | -97.20%-408.2M | 131.09%95.9M | -246.97%-252.2M | 151.71%163.1M | 38.26%507M | ---207M |
| -Change in receivables | ---- | ---- | 199.00%330.1M | ---- | ---- | ---- | ---- | 3.66%110.4M | ---- | ---- |
| -Change in inventory | ---- | ---- | 758.25%176.8M | ---- | ---- | ---- | ---- | -89.84%20.6M | ---- | ---- |
| -Change in prepaid assets | ---- | ---- | -451.61%-21.8M | ---- | ---- | ---- | ---- | 205.08%6.2M | ---- | ---- |
| -Change in payables and accrued expense | ---- | ---- | -1,451.74%-350.1M | ---- | ---- | ---- | ---- | 104.48%25.9M | ---- | ---- |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -188.62%-119.2M | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -9.37%1.2B | 28.64%1.26B | 4.56%5.04B | 17.59%1.79B | -3.78%938M | 42.35%1.33B | -29.23%983.1M | 10.88%4.82B | 6.78%1.52B | --974.8M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -1,390.96%-485.4M | -1,361.18%-1.86B | 75.95%-1.59B | -21.09%-685.5M | 82.71%-813.7M | 103.74%37.6M | 61.54%-127.5M | -190.39%-6.61B | 43.73%-566.1M | -4.71B |
| Net PPE purchase and sale | 8.53%-445.1M | 23.05%-255.1M | -18.08%-2.19B | -18.72%-683.6M | -14.07%-689.8M | -20.83%-486.6M | -21.52%-331.5M | -20.39%-1.86B | -30.12%-575.8M | ---604.7M |
| Net business purchase and sale | -1,196.67%-38.9M | -854.01%-1.61B | 102.02%86.8M | -129.41%-3.9M | 97.19%-119.6M | 91.35%-3M | 2,131.43%213.3M | -389.43%-4.3B | 99.73%-1.7M | ---4.25B |
| Net investment purchase and sale | --0 | 260.00%8M | 213.34%515.6M | -101.91%-300K | --0 | 191.29%520.9M | 90.51%-5M | -428.21%-454.9M | -76.46%15.7M | --152.7M |
| Net other investing changes | -122.22%-1.4M | -76.74%-7.6M | 19.05%5M | 7,400.00%7.3M | -13.16%-4.3M | 75.00%6.3M | -195.56%-4.3M | -23.64%4.2M | 98.61%-100K | ---3.8M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -1,390.96%-485.4M | -1,361.18%-1.86B | 76.01%-1.58B | -21.11%-680.5M | 82.71%-813.7M | 103.74%37.6M | 61.54%-127.5M | -190.20%-6.6B | 44.15%-561.9M | ---4.71B |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 2.31%-767.1M | 191.10%519M | -215.08%-2.54B | 8.26%-622.7M | -117.02%-560.3M | -72.95%-785.2M | -1,354.85%-569.7M | 165.84%2.21B | 11.37%-678.8M | 3.29B |
| Net issuance payments of debt | 306.39%216.3M | 278.20%745.4M | -136.53%-1.45B | -66.62%-492.2M | -112.12%-433M | -133.76%-104.8M | -211.16%-418.3M | 778.04%3.97B | -45.16%-295.4M | --3.57B |
| Net common stock issuance | -67.88%-854M | 65.54%-10.2M | 60.11%-538.3M | --0 | --0 | 24.40%-508.7M | 87.13%-29.6M | 43.60%-1.35B | 41.74%-270.6M | ---175.9M |
| Cash dividends paid | -7.07%-131.8M | -10.13%-134.8M | -11.55%-505.3M | -6.45%-130.3M | -2.61%-129.5M | -22.73%-123.1M | -17.58%-122.4M | -19.94%-453M | -19.77%-122.4M | ---126.2M |
| Proceeds from stock option exercised by employees | --2.4M | --0 | -92.18%2.8M | --0 | -89.52%2.2M | --0 | -81.25%600K | 575.47%35.8M | -34.88%2.8M | --21M |
| Net other financing activities | ---- | ---81.4M | -817.65%-48.8M | ---200K | ---- | ---48.6M | ---- | --6.8M | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 2.31%-767.1M | 191.10%519M | -215.08%-2.54B | 8.26%-622.7M | -117.02%-560.3M | -72.95%-785.2M | -1,354.85%-569.7M | 165.84%2.21B | 11.37%-678.8M | --3.29B |
| Net cash flow | ||||||||||
| Beginning cash position | 36.53%2.19B | 72.88%2.26B | 56.92%1.31B | 68.88%1.7B | 53.98%2.16B | -17.89%1.61B | 56.92%1.31B | -61.09%834.2M | -11.40%1B | --1.4B |
| Current changes in cash | -108.20%-47.7M | -127.74%-79.3M | 118.56%915.1M | 73.48%483.5M | 0.57%-436M | 210.88%581.7M | -74.08%285.9M | 132.69%418.7M | 179.83%278.7M | ---438.5M |
| Effect of exchange rate changes | 16.27%-21.1M | -16.38%9.7M | -30.66%38.9M | 220.77%83.4M | -181.10%-30.9M | 7.69%-25.2M | -39.90%11.6M | 293.45%56.1M | -47.79%26M | --38.1M |
| End cash Position | -1.78%2.12B | 36.53%2.19B | 72.88%2.26B | 72.88%2.26B | 68.88%1.7B | 53.98%2.16B | -17.89%1.61B | 56.92%1.31B | 56.92%1.31B | --1B |
| Free cash from | -9.21%742.9M | 45.60%848.1M | -5.69%2.71B | 20.33%1.09B | -38.07%224.3M | 58.80%818.3M | -46.78%582.5M | 13.12%2.87B | 9.44%902M | --362.2M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.